글로벌 치료 계획 시스템 시장 - 2029년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 글로벌 치료 계획 시스템 시장

Data Bridge Market Research에 따르면 치료 계획 시스템 시장은 2022~2029년 예측 기간 동안 7.70%의 CAGR로 성장할 것으로 분석됩니다.

여성 건강 관리 분야의 기술적 발전은 다양한 여성 관련 문제에 대한 해결책을 제공했습니다. 디지털 도구는 낮은 가치와 높은 접근성으로 맞춤화된 예방적 치료 접근 방식을 용이하게 합니다. 컴퓨터 과학 및 정보 과학과 같은 진보된 기술은 여성에게 건강 지표를 따라 건강에 대한 권장 선택을 형성하여 맞춤화된 통찰력을 제공합니다.

암의 유병률 증가는 치료 계획 시스템 시장을 주도하는 주요 요인입니다. 나아가 방사선과 의학에 대한 투자와 전략적 이니셔티브가 증가하고, 기술적으로 진보된 방사선 치료 기계와 소프트웨어 시스템을 도입하는 방사선 치료 센터와 병원의 종류가 늘어나고, 의학 소프트웨어 시스템에서 AI/ML을 도입하는 것이 시장을 주도하는 주요 요인입니다. 그러나 정보 기술 및 방사선 분야의 주의 인력 부족과 자본 집약적 시장은 치료 계획 시스템 시장의 주요 제약으로 작용합니다.

게다가 암 진행 상황을 실시간으로 모니터링하고 추적하며 방사선 치료가 널리 도입됨에 따라 치료 계획 시스템 시장에 많은 기회가 생길 것입니다.

This treatment planning systems market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on treatment planning systems contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Treatment Planning Systems Market Scope and Market Size

The treatment planning systems is segmented on the basis of component, technique, and application. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of component, the treatment planning systems market is segmented into advanced image processing software, treatment planning software, auto-contouring software, multi-modality software, PET/CT deformable software, and DICOM-RT software.
• On the basis of technique, the treatment planning systems market is segmented into 3D image reconstruction, in-room imaging, and image registration using graphics processor unit.
• On the basis of application, the treatment planning systems market is segmented into adaptive radiotherapy, online monitoring, tracking, dose accumulation, and validation of image registration.

Treatment Planning Systems Market Country Level Analysis

The treatment planning systems market is analysed and market size insights and trends are provided by country, component, technique, and application as referenced above.

The countries covered in the treatment planning systems market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the treatment planning systems market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is owing to rapid advancements in healthcare infrastructure coupled with increased healthcare expenditure. Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period due to the growth of many developing economies such as India and China.

The country section of the treatment planning systems market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The treatment planning systems also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for treatment planning systems, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the treatment planning systems. The data is available for historic period 2010 to 2020.

Competitive Landscape and Treatment Planning Systems Market Share Analysis

The treatment planning systems market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to treatment planning systems.

Some of the major players operating in the treatment planning systems market report are DOSIsoft SA, Koninklijke Philips N.V., MIM Software Inc., RaySearch Laboratories, Elekta AB, Brainlab AG, IBA Worldwide, Accuray Incorporated, VIEWRAY TECHNOLOGIES, INC., Varian Medical Systems, Inc., Institut Straumann AG, Nobel Biocare Services AG, CAMLOG Biotechnologies AG, medentis medical GmbH, BEGO Medical GmbH, Dentsply Sirona., Zimmer Biomet, Sweden & Martina S.p.A., MIS IMPLANTS TECHNOLOGIES LTD., 3D Diagnostix, 3DIEMME srl, ACE Surgical Supply Co., Alpha-Bio Tec Ltd., Blue Sky Bio, Biocon, and Thommen Medical AG among others.

SKU-67145